The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gastrointestinal Stromal Tumor Market Research Report 2024
Synopsis
Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.
The global Gastrointestinal Stromal Tumor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as pathologists. Until now, the role of radiotherapy in treatment of gastrointestinal stromal tumor remains decisively unestablished. For being inoperable, patients suffering from this malignant tumor opt for symptomatic treatments such as conventional chemotherapy.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor.
Report Scope
The Gastrointestinal Stromal Tumor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Stromal Tumor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Stromal Tumor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Pfizer
Bayer Aktiengesellschaft
NATCO Pharma
Segment by Type
Stomach
Small Intestine
Others
Segment by Application
Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract.
The global Gastrointestinal Stromal Tumor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as pathologists. Until now, the role of radiotherapy in treatment of gastrointestinal stromal tumor remains decisively unestablished. For being inoperable, patients suffering from this malignant tumor opt for symptomatic treatments such as conventional chemotherapy.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal Stromal Tumor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal Stromal Tumor.
Report Scope
The Gastrointestinal Stromal Tumor market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal Stromal Tumor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal Stromal Tumor companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Pfizer
Bayer Aktiengesellschaft
NATCO Pharma
Segment by Type
Stomach
Small Intestine
Others
Segment by Application
Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stomach
1.2.3 Small Intestine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Specialized Cancer Treatment Centers
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Market Perspective (2019-2030)
2.2 Gastrointestinal Stromal Tumor Growth Trends by Region
2.2.1 Global Gastrointestinal Stromal Tumor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastrointestinal Stromal Tumor Historic Market Size by Region (2019-2024)
2.2.3 Gastrointestinal Stromal Tumor Forecasted Market Size by Region (2025-2030)
2.3 Gastrointestinal Stromal Tumor Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Players by Revenue (2019-2024)
3.1.2 Global Gastrointestinal Stromal Tumor Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Revenue
3.4 Global Gastrointestinal Stromal Tumor Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Revenue in 2023
3.5 Gastrointestinal Stromal Tumor Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Stromal Tumor Product Solution and Service
3.7 Date of Enter into Gastrointestinal Stromal Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Type (2019-2024)
4.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Type (2025-2030)
5 Gastrointestinal Stromal Tumor Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Historic Market Size by Application (2019-2024)
5.2 Global Gastrointestinal Stromal Tumor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Market Size (2019-2030)
6.2 North America Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastrointestinal Stromal Tumor Market Size by Country (2019-2024)
6.4 North America Gastrointestinal Stromal Tumor Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Market Size (2019-2030)
7.2 Europe Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastrointestinal Stromal Tumor Market Size by Country (2019-2024)
7.4 Europe Gastrointestinal Stromal Tumor Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Market Size (2019-2030)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Market Size (2019-2030)
9.2 Latin America Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2019-2024)
9.4 Latin America Gastrointestinal Stromal Tumor Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Market Size (2019-2030)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Gastrointestinal Stromal Tumor Introduction
11.1.4 Novartis Revenue in Gastrointestinal Stromal Tumor Business (2019-2024)
11.1.5 Novartis Recent Development
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Detail
11.2.2 Sun Pharmaceutical Business Overview
11.2.3 Sun Pharmaceutical Gastrointestinal Stromal Tumor Introduction
11.2.4 Sun Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Business (2019-2024)
11.2.5 Sun Pharmaceutical Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Gastrointestinal Stromal Tumor Introduction
11.3.4 Pfizer Revenue in Gastrointestinal Stromal Tumor Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Bayer Aktiengesellschaft
11.4.1 Bayer Aktiengesellschaft Company Detail
11.4.2 Bayer Aktiengesellschaft Business Overview
11.4.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Introduction
11.4.4 Bayer Aktiengesellschaft Revenue in Gastrointestinal Stromal Tumor Business (2019-2024)
11.4.5 Bayer Aktiengesellschaft Recent Development
11.5 NATCO Pharma
11.5.1 NATCO Pharma Company Detail
11.5.2 NATCO Pharma Business Overview
11.5.3 NATCO Pharma Gastrointestinal Stromal Tumor Introduction
11.5.4 NATCO Pharma Revenue in Gastrointestinal Stromal Tumor Business (2019-2024)
11.5.5 NATCO Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
